Posted November 22, 2019
The September 24th issue of the Journal of the American Medical Association (“JAMA”) reprinted[1] an article originally published in The Medical Letter on Drugs and Therapeutics which told us about the latest “hormone” therapy “approved” by our “public servants” in Washington DC. The article tells us: “Bijuva® is supplied in capsules containing 1 mg of estradiol and 100 mg of progesterone. The recommended dosage is 1 capsule every evening with food. The oral fixed-dose combination….” Read more.